Biodexa Pharmaceuticals Balance Sheet (2013-2026)

Reported Financials

Biodexa Pharmaceuticals Quarterly Balance Sheet

Periods 24 quarters

Latest Jun 2026

Biodexa Pharmaceuticals reported total assets of $17.07M and total liabilities of $4.17M for the quarter ended Jun 2026, down 3.2% year over year. This balance sheet covers 24 quarters of results from Dec 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Dec2016	Jun2017	Dec2017	Jun2018	Dec2018	Jun2019	Dec2019	Jun2020	Dec2020	Jun2021	Dec2021	Jun2022	Dec2022	Jun2023	Dec2023	Jun2024	Dec2024	Jun2025	Dec2025	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	21.89M	7.90M	17.53M	5.92M	3.01M	11.55M	14.05M	5.37M	9.96M	5.88M	13.56M	8.09M	3.33M	6.54M	7.41M	6.38M	2.14M	5.38M	11.35M	4.33M
Cash & Current Investments	21.89M	7.90M	17.53M	5.92M	3.01M	11.55M	14.05M	5.37M	9.96M	5.88M	13.56M	8.09M	3.33M	6.54M	7.41M	6.38M	2.14M	5.38M	11.35M	4.33M
Receivables	4.67M	3.30M	5.43M	0.98M	4.32M	3.89M	9.08M	4.56M	1.04M	1.96M	1.92M	1.57M	1.53M	1.13M	1.14M	2.43M	8.60M	6.00M	5.12M	3.94M
Finished Goods	1.02M		1.25M
Inventory	1.02M	1.17M	1.25M	1.35M	0.81M
Prepaid Assets					0.18M	0.46M			0.34M		0.82M		0.44M
Current Assets	27.73M	14.96M	24.67M	27.91M	7.23M	18.43M	17.66M	12.75M	12.25M	9.82M	15.85M	10.94M	5.50M	9.09M	8.73M	9.50M	11.31M	12.00M	16.55M	8.98M
Non-Current Assets
Property, Plant & Equipment (Net)	3.44M	3.49M	3.36M	3.43M	2.55M	2.25M	2.77M	1.18M	0.72M	1.74M	1.55M	1.25M	0.97M	0.87M	0.71M	0.55M	0.42M	0.25M	0.12M	0.03M
Long-Term Investments
Goodwill			17.79M	9.11M	2.96M		2.96M					1.25M
Intangibles	20.73M		13.41M		13.00M		12.99M						18.51M		3.65M	27.50M	7.25M		7.51M	8.06M
Goodwill & Intangibles	34.37M	38.83M	36.71M	16.87M	15.92M	15.92M	15.92M	0.97M	20.69M		21.12M	1.25M	0.01M	0.01M	3.65M	7.58M	7.25M	7.53M	7.51M	8.06M
Long-Term Deferred Tax	10.07M		12.61M		2.19M		2.06M		2.11M		22.78M		21.00M		23.46M		25.54M		27.27M
Other Non-Current Assets				18.44M
Non-Current Assets	42.75M	42.90M	40.68M	20.93M	19.08M	18.27M	22.06M	2.15M	0.72M	1.74M	1.55M	1.25M	0.98M	0.87M	4.36M	8.13M	7.66M	7.78M	7.63M	8.09M
Assets	70.48M	57.86M	65.35M	48.84M	26.31M	36.70M	39.72M	14.90M	12.96M	11.57M	17.41M	12.19M	6.48M	9.96M	13.08M	17.63M	18.97M	19.78M	24.18M	17.07M
Liabilities
Current Liabilities
Accounts Payables	10.45M	8.49M	10.62M	4.69M	2.71M	3.25M	5.78M	3.46M	1.62M	2.85M	1.47M	1.61M	1.70M	2.20M	1.54M	2.13M	4.50M	1.89M	3.45M	2.19M
Notes Payables		0.71M	0.48M	0.71M		0.91M		4.22M		0.18M		0.21M		0.21M		0.22M		0.67M
Payables	10.45M	9.21M	11.10M	5.40M	2.71M	4.16M	5.78M	7.68M	1.62M	3.03M	1.47M	1.82M	1.70M	2.40M	1.54M	2.35M	4.50M	2.55M	3.45M	2.19M
Other Accumulated Expenses																0.58M	0.69M	0.70M	0.75M	0.82M
Short term Debt	0.67M		0.01M		0.47M		0.53M		0.26M		0.20M		0.19M		0.21M		0.78M		0.08M
Current Deferred Revenue	7.93M
Curent Deferred Tax Liability																0.58M	0.69M	0.70M	0.75M	0.82M
Total Current Liabilities	11.62M	9.26M	11.10M	8.61M	3.18M	0.21M	0.12M	9.12M	3.95M	0.07M	2.48M	2.07M	2.23M	2.86M	6.91M	4.39M	6.46M	3.31M	8.15M	3.73M
Non-Current Liabilities
Capital Leases	0.06M		0.04M
Non-Current Debt	2.01M	1.56M	8.21M	8.39M	1.14M	0.49M	7.29M	0.13M	0.08M	0.95M	0.84M	0.69M	0.54M	0.48M	0.37M	0.26M	0.15M
Convertible Debt					0.21M		0.12M		0.07M		0.07M	0.05M	0.24M
Preferred Stock Liabilities
Liabilities from Discontinued Operations				3.21M
Operating Leases			0.05M		0.10M		0.30M						0.19M		0.21M		0.23M
Non-Current Deferred Tax Liability
Other Non-Current Liabilities					-0.60M	-0.10M	0.85M	1.43M	2.06M	2.27M	0.75M	0.20M	0.10M	0.46M	5.16M	1.96M	1.68M	1.21M	0.86M	0.44M
Total Non-Current Liabilities	2.01M	1.56M	8.21M	8.39M	1.35M	0.49M	7.29M	0.13M	0.15M	0.95M	0.84M	0.69M	0.54M	0.48M	0.37M	2.22M	1.83M	1.21M	0.86M	0.44M
Total Liabilities	13.63M	10.82M	19.31M	17.00M	4.53M	4.87M	14.58M	9.25M	4.09M	6.32M	3.32M	2.76M	2.77M	3.33M	7.28M	6.62M	8.29M	4.52M	9.01M	4.17M
Shareholder's Equity
Total Debt	2.68M	2.27M	8.71M	9.10M	1.61M	1.41M	7.82M	4.36M	0.34M	1.13M	1.03M	0.90M	0.73M	0.68M	0.58M	0.48M	0.93M	0.67M	0.08M
Common Equity	56.85M	47.04M	46.04M	31.84M	21.78M	31.84M	25.15M	5.65M	8.87M	5.24M	14.09M	9.43M	3.71M	6.63M	5.81M	11.02M	10.68M	15.26M	15.17M	12.90M
Liabilities and Shareholders Equity	70.48M	57.86M	65.35M	48.84M	26.31M	36.70M	39.72M	14.90M	12.96M	11.57M	17.41M	12.19M	6.48M	9.96M	13.08M	17.63M	18.97M	19.78M	24.18M	17.07M
Retained Earnings	-73.49M	-86.73M	-99.12M	-117.38M	-115.45M	-121.06M	-128.37M	-146.19M	-161.67M	-175.48M	-172.28M	-164.67M	-158.74M	-173.91M	-179.68M	-186.66M	-193.07M	-205.62M	-207.25M	-211.45M

Biodexa Pharmaceuticals Balance Sheet API

Pull Biodexa Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BDRX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "BDRX", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=BDRX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Biodexa Pharmaceuticals BDRX Balance Sheet (2013-2026)

Biodexa Pharmaceuticals Quarterly Balance Sheet

Biodexa Pharmaceuticals Balance Sheet API

Create an account

Sign In

Reset Password